Frank Herringer - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Independent Director

Mr. Frank C. Herringer is an Independent Director of Amgen Inc. Frank C. Herringer was a director of the Board of Transamerica Corporationrationration, a financial services company, since 1986, serving as Chairman of the board of directors from 1995 to December 2015. Mr. Herringer was an executive with Transamerica for 20 years, including its Chief Executive Officer from 1991 until its acquisition by Aegon N.V., a life insurance, pensions and asset management company, in 1999, subsequently serving on Aegons Executive Board for one year. Mr. Herringer was a director of Aegon U.S. Holding Corporationrationration from 1999 until its merger into Transamerica Corporationrationration in December 2015.
Age: 73  Director Since 2004      
805 447-1010  www.amgen.com
Herringer received an undergraduate degree and master?s degree in business administration from Dartmouth College.

Frank Herringer Latest Insider Activity

Frank Herringer over a month ago via Macroaxis 
Charles Schwab exotic insider transaction detected
Frank Herringer over two months ago via Macroaxis 
Amgen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Louis DrapeauBio Rad Laboratories Inc
2007
Nancy HutsonEndo International plc
2009
James BloemAllergan plc
2013
Ronald TaylorAllergan plc
2013
Elaine UllianVertex Pharmaceuticals Incorpor
2011
William OsbornAbbott Laboratories
2013
Catherine KlemaAllergan plc
2016
Ron TaylorAllergan plc
2013
Adriane BrownAllergan plc
2017
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Deborah NeffBio Rad Laboratories Inc
2011
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Christopher CoughlinAllergan plc
2016
William YoungVertex Pharmaceuticals Incorpor
2014
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Samuel ScottAbbott Laboratories
2007
Nancy McKinstryAbbott Laboratories
2011
Nesli BasgozAllergan plc
2014
Todd SisitskyEndo International plc
2016
Michael HyattEndo International plc
N/A
Roxanne AustinAbbott Laboratories
2000

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators